Candidal intertrigo, also known as intertriginous candidiasis or yeast infection in skin folds, is a common fungal infection affecting skin folds. Learn about diagnosis, clinical documentation, and medical coding for candidal intertrigo (ICD-10 code B37.8) including treatment options and prevention strategies. This resource provides information for healthcare professionals on yeast intertrigo management and best practices.
Fungal skin infection in warm, moist body folds caused by Candida yeast.
Red, itchy rash with satellite pustules or papules in skin folds like armpits, groin, or under breasts.
Obesity, diabetes, antibiotic use, and warm, humid environments.
Complete code families applicable to B37.2
| Description | When to use |
|---|---|
| Yeast infection in skin folds. | Skin folds red, itchy, satellite lesions. Confirm with KOH. |
| Bacterial skin fold infection. | Skin folds red, painful, may have pus. Consider cultures. |
| Skin fold irritation, not infection. | Red, itchy skin folds, no pus or satellite lesions. Rule out infection. |
Coding candidal intertrigo without specifying the affected body area can lead to claim rejections. Use site-specific ICD-10 codes (e.g., B37.1, B37.8).
Lack of proper documentation to support the diagnosis of candidal intertrigo can raise audit red flags. CDI specialists should query for supporting clinical findings.
Coding candidal intertrigo as confirmed when documented as "rule out" or "suspected" is incorrect and poses compliance risks. Code based on definitive diagnosis.
Confirm intertriginous rash: Location in skin folds (e.g., axillae, groin, inframammary folds)
Identify hallmark signs: Beefy-red plaques, satellite pustules, maceration
KOH microscopy: Pseudohyphae and/or budding yeast cells present
Consider differential diagnoses: Seborrheic dermatitis, psoriasis, contact dermatitis
Patient presents with intertriginous candidiasis, also known as candidal intertrigo or a yeast infection in skin folds, affecting the [specify location, e.g., axilla, groin, inframammary folds]. The affected area exhibits erythema, maceration, and satellite lesions characteristic of yeast intertrigo. Patient reports [symptoms, e.g., pruritus, burning, discomfort] exacerbated by friction and moisture. Clinical examination reveals [detailed findings, e.g., well-demarcated erythematous plaques with peripheral scaling, pustules, or erosions]. Differential diagnoses considered include intertrigo, contact dermatitis, and psoriasis. Diagnosis of candidal intertrigo is based on clinical presentation and may be confirmed with potassium hydroxide (KOH) preparation demonstrating pseudohyphae and budding yeast. Treatment plan includes topical antifungal therapy with [specify medication, e.g., clotrimazole, nystatin] applied twice daily for [duration]. Patient education provided on maintaining skin hygiene, keeping the area dry, and avoiding occlusive clothing. Follow-up scheduled in [timeframe] to assess treatment response and adjust management as needed. ICD-10 code B37.1 is assigned for candidiasis of skin and nails. This documentation supports medical necessity for the prescribed treatment.
Differentiating candidal intertrigo from other intertriginous dermatoses like psoriasis, erythrasma, and contact dermatitis requires careful clinical evaluation. Candidal intertrigo typically presents as erythematous plaques with satellite papules and pustules, often with a glazed appearance, within skin folds like the axillae, groin, inframammary folds, and interdigital spaces. Psoriasis in these areas may lack the typical silvery scale and appear more as smooth, shiny plaques. Erythrasma exhibits coral-red fluorescence under a Wood's lamp, unlike candidal intertrigo. Contact dermatitis often presents with more intense pruritus and vesicles, and its distribution may correlate with allergen exposure. Microscopic examination with KOH preparation can confirm the presence of yeast in candidal intertrigo. Consider implementing a stepwise approach including patient history, visual inspection, Wood's lamp examination, and KOH microscopy for accurate diagnosis. Explore how combining clinical findings with diagnostic tests can improve diagnostic accuracy in intertriginous dermatoses.
Recurrent candidal intertrigo in obese patients presents unique challenges due to persistent skin-on-skin friction and moisture retention. Topical antifungals like nystatin, clotrimazole, ketoconazole, and econazole are effective, but adherence and proper application are crucial. Cream formulations are generally preferred over ointments in intertriginous areas due to their drying effect. For severe or resistant cases, a short course of oral fluconazole may be considered in consultation with a specialist. Addressing underlying predisposing factors like hyperhidrosis and diabetes is essential for long-term management. Explore how weight management strategies and moisture control measures can complement topical antifungal therapy to reduce recurrence rates. Learn more about strategies for optimizing topical antifungal application in obese patients to enhance treatment efficacy.
Patients with diabetes are at increased risk of candidal intertrigo due to hyperglycemia and impaired immune function. Meticulous hygiene practices, including regular cleansing and thorough drying of skin folds, are crucial. Loose-fitting clothing made of breathable fabrics like cotton can help minimize friction and moisture accumulation. Controlling blood glucose levels through appropriate diabetes management is essential to reduce the risk of infection. Consider implementing strategies for weight management if applicable, as obesity can exacerbate intertrigo. Learn more about the interplay between diabetes control and skin health to empower patients with effective preventive measures. Explore how patient education on proper hygiene and skin care can minimize the risk of candidal intertrigo and improve overall quality of life.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.